Welch Group, LLC Bristol Myers Squibb CO Transaction History

Welch Group, LLC

$2.08 Billion
Q2 2024

A detailed history of Welch Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Welch Group, LLC holds 16,337 shares of BMY stock, worth $831,880. This represents 0.03% of its overall portfolio holdings.

Number of Shares

16,337

Previous 16,682 2.07%

Holding current value

$831,880

Previous $904,000 25.0%

% of portfolio

0.03%

Previous 0.04%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 17, 2024	SELL	$40.25 - $52.99 $13,886 - $18,281	-345 Reduced 2.07%	16,337 $678,000
Q1 2024 Apr 09, 2024	SELL	$47.98 - $54.4 $3.21 Million - $3.64 Million	-66,868 Reduced 80.03%	16,682 $904,000
Q4 2023 Jan 22, 2024	SELL	$48.48 - $57.85 $209,579 - $250,085	-4,323 Reduced 4.92%	83,550 $4.29 Million
Q3 2023 Oct 18, 2023	BUY	$57.89 - $64.73 $217,492 - $243,190	3,757 Added 4.47%	87,873 $5.1 Million
Q2 2023 Jul 18, 2023	BUY	$63.71 - $70.74 $315,683 - $350,516	4,955 Added 6.26%	84,116 $5.38 Million
Q1 2023 Apr 13, 2023	BUY	$65.71 - $74.53 $240,170 - $272,407	3,655 Added 4.84%	79,161 $5.49 Million
Q4 2022 Jan 27, 2023	BUY	$68.48 - $81.09 $134,494 - $159,260	1,964 Added 2.67%	75,506 $5.43 Million
Q3 2022 Oct 13, 2022	BUY	$0.13 - $76.84 $104 - $61,548	801 Added 1.1%	73,542 $5.23 Million
Q2 2022 Jul 21, 2022	BUY	$72.62 - $79.98 $72,692 - $80,059	1,001 Added 1.4%	72,741 $5.6 Million
Q1 2022 Apr 29, 2022	BUY	$61.48 - $73.72 $569,120 - $682,426	9,257 Added 14.82%	71,740 $5.24 Million
Q4 2021 Jan 26, 2022	BUY	$53.63 - $62.52 $200,468 - $233,699	3,738 Added 6.36%	62,483 $3.9 Million
Q3 2021 Nov 05, 2021	BUY	$59.17 - $69.31 $486,140 - $569,450	8,216 Added 16.26%	58,745 $3.48 Million
Q2 2021 Jul 21, 2021	BUY	$61.91 - $67.42 $279,461 - $304,333	4,514 Added 9.81%	50,529 $3.38 Million
Q1 2021 Apr 23, 2021	BUY	$59.34 - $66.74 $762,459 - $857,542	12,849 Added 38.74%	46,015 $2.91 Million
Q4 2020 Jan 25, 2021	BUY	$57.74 - $65.43 $141,636 - $160,499	2,453 Added 7.99%	33,166 $2.06 Million
Q3 2020 Oct 28, 2020	BUY	$57.43 - $63.64 $327,580 - $363,002	5,704 Added 22.81%	30,713 $1.85 Million
Q2 2020 Jul 22, 2020	BUY	$54.82 - $64.09 $67,264 - $78,638	1,227 Added 5.16%	25,009 $1.47 Million
Q1 2020 Apr 28, 2020	BUY	$46.4 - $67.43 $446,646 - $649,081	9,626 Added 68.0%	23,782 $1.33 Million
Q4 2019 Jan 24, 2020	BUY	$49.21 - $64.19 $162,786 - $212,340	3,308 Added 30.49%	14,156 $909,000
Q3 2019 Nov 05, 2019	BUY	$42.77 - $50.71 $19,973 - $23,681	467 Added 4.5%	10,848 $550,000
Q2 2019 Jul 11, 2019	SELL	$44.62 - $49.34 $31,010 - $34,291	-695 Reduced 6.27%	10,381 $471,000
Q4 2018 Jan 10, 2019	SELL	$48.76 - $63.23 $9,752 - $12,646	-200 Reduced 1.77%	11,076 $576,000
Q2 2018 Jul 30, 2018	BUY	$50.53 - $62.98 $2,324 - $2,897	46 Added 0.41%	11,276 $624,000
Q1 2018 Apr 23, 2018	BUY	$59.92 - $68.98 $129,007 - $148,513	2,153 Added 23.72%	11,230 $710,000
Q4 2017 Feb 01, 2018	SELL	$59.94 - $65.35 $28,051 - $30,583	-468 Reduced 4.9%	9,077 $556,000
Q3 2017 Nov 07, 2017	BUY	$55.23 - $63.74 $16,569 - $19,122	300 Added 3.24%	9,545 $308,000
Q2 2017 Aug 07, 2017	BUY	N/A	9,245	9,245 $515,000

Others Institutions Holding BMY

# of Institutions

2,400

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $108B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Welch Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Welch Group, LLC with notifications on news.

Account